ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
March 31, 2022LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets... -
LianBio Announces Mavacamten Granted Breakthrough Therapy Designation in China
February 16, 2022LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines... -
LianBio Provides Corporate Update and Reports Third Quarter 2021 Financial Results
December 10, 2021LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.
Pharma Sources Insight January 2025
